<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ___)*
CARDIOGENESIS CORPORATION
------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
------------------------------------------------------------------------------
(Title of Class of Securities)
14159K 10 5
------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
SCHEDULE 13G
- --------------------------- --------------------------
CUSIP NO. 14159K 10 5 PAGE 2 OF 10 PAGES
- --------------------------- --------------------------
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
VANGUARD IV, L.P.
------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
------------------------------------------------------------------------
NUMBER 5 SOLE VOTING POWER 0
OF
SHARES ------------------------------------------------------------
BENEFICIALLY
OWNED 6 SHARED VOTING POWER 1,472,273
BY
EACH ------------------------------------------------------------
REPORTING
PERSON 7 SOLE DISPOSITIVE POWER 0
WITH ------------------------------------------------------------
8 SHARED DISPOSITIVE POWER 1,472,273
------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,472,273
------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.34%
------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- -------------------------------------------------------------------------------
<PAGE> 3
SCHEDULE 13G
- --------------------------- --------------------------
CUSIP NO. 14159K 10 5 PAGE 3 OF 10 PAGES
- --------------------------- --------------------------
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
VANGUARD VENTURE PARTNERS
------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
------------------------------------------------------------------------
NUMBER 5 SOLE VOTING POWER 0
OF
SHARES ------------------------------------------------------------
BENEFICIALLY
OWNED 6 SHARED VOTING POWER 1,472,273
BY
EACH ------------------------------------------------------------
REPORTING
PERSON 7 SOLE DISPOSITIVE POWER 0
WITH ------------------------------------------------------------
8 SHARED DISPOSITIVE POWER 1,472,273
------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,472,273
------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.34%
------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- -------------------------------------------------------------------------------
<PAGE> 4
SCHEDULE 13G
- --------------------------- --------------------------
CUSIP NO. 14159K 10 5 PAGE 4 OF 10 PAGES
- --------------------------- --------------------------
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
JACK M. GILL
------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
------------------------------------------------------------------------
NUMBER 5 SOLE VOTING POWER 0
OF
SHARES ------------------------------------------------------------
BENEFICIALLY
OWNED 6 SHARED VOTING POWER 1,472,273
BY
EACH ------------------------------------------------------------
REPORTING
PERSON 7 SOLE DISPOSITIVE POWER 0
WITH ------------------------------------------------------------
8 SHARED DISPOSITIVE POWER 1,472,273
------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,472,273
------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.34%
------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
<PAGE> 5
SCHEDULE 13G
- --------------------------- --------------------------
CUSIP NO. 14159K 10 5 PAGE 5 OF 10 PAGES
- --------------------------- --------------------------
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
CURTIS K. MYERS
------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
------------------------------------------------------------------------
NUMBER 5 SOLE VOTING POWER 0
OF
SHARES ------------------------------------------------------------
BENEFICIALLY
OWNED 6 SHARED VOTING POWER 1,472,273
BY
EACH ------------------------------------------------------------
REPORTING
PERSON 7 SOLE DISPOSITIVE POWER 0
WITH ------------------------------------------------------------
8 SHARED DISPOSITIVE POWER 1,472,273
------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,472,273
------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.34%
------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
<PAGE> 6
SCHEDULE 13G
- --------------------------- --------------------------
CUSIP NO. 14159K 10 5 PAGE 6 OF 10 PAGES
- --------------------------- --------------------------
- -------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
CLIFFORD H. HIGGERSON
------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
(B) [ ]
------------------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
------------------------------------------------------------------------
NUMBER 5 SOLE VOTING POWER 0
OF
SHARES ------------------------------------------------------------
BENEFICIALLY
OWNED 6 SHARED VOTING POWER 1,472,273
BY
EACH ------------------------------------------------------------
REPORTING
PERSON 7 SOLE DISPOSITIVE POWER 0
WITH ------------------------------------------------------------
8 SHARED DISPOSITIVE POWER 1,472,273
------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,472,273
------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.34%
------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
<PAGE> 7
ITEM 1.
(a) Name of Issuer:
CardioGenesis Corporation
(b) Address of Issuer's Principal Executive Offices:
540 Oakmead Parkway
Sunnyvale, California 94086
ITEM 2.
(a) Name of Person Filing:
Vanguard IV, L.P. ("Vanguard"); Vanguard Venture Partners ("VVP")
is the general partner of Vanguard; Jack M. Gill, Curtis K. Myers
and Clifford H. Higgerson are the general partners of VVP.
(b) Address of Principal Business Office:
525 University Avenue, Suite 600
Palo Alto, CA 94301
(c) Citizenship:
Vanguard and VVP are Delaware limited partnerships; Messrs. Gill,
Myers and Higgerson are United States citizens.
(d) Title of Class of Securities:
Common Stock
(e) CUSIP Number:
14159K 10 5
ITEM 3.
Not applicable.
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned:
Vanguard is the record holder of 1,472,273 shares of Common Stock
and may be deemed to beneficially own 1,472,273 shares of Common
Stock. VVP, as the general partner of Vanguard, may be deemed to
beneficially own 1,472,273 shares of Common Stock. Each of Messrs.
Gill, Myers and Higgerson, as the general partners of VVP, may be
deemed to beneficially own 1,472,273 shares of Common Stock. The
filing of this statement shall not be construed as an admission that
any of the reporting persons are, for the purpose of Section 13(d)
or 13(g) of the Act, the beneficial owners of any securities covered
by this statement.
(b) Percent of Class:
<TABLE>
<S> <C>
Vanguard 12.34%
VVP 12.34%
Jack M. Gill 12.34%
Curtis K. Myers 12.34%
Clifford H. Higgerson 12.34%
</TABLE>
<PAGE> 8
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote; (ii) shared power to
vote or direct the vote; (iii) sole power to dispose or to direct
the disposition of; or (iv) shared power to dispose or to direct the
disposition of:
Vanguard may be deemed to have shared power to vote and shared power
to dispose of 1,472,273 shares of Common Stock. VVP, as the general
partner of Vanguard, may be deemed to have shared power to vote and
shared power to dispose of 1,472,273 shares of Common Stock. Each of
Messrs. Gill, Myers and Higgerson, as the general partners of VVP,
may be deemed to have shared power to vote and shared power to
dispose of 1,472,273 shares of Common Stock.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION MEMBERS OF THE GROUP
See Item 4(c) (i)-(iv) and Exhibit 1, Agreement With Respect to
Joint Filing of Schedule 13G, pursuant to Rule 13d-1(f) promulgated
under the Securities Exchange Act of 1934, as amended.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
ITEM 10. CERTIFICATION
By signing below, I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose of
and do not have the effect of changing or influencing the control of
the issuer of such securities and were not acquired in connection
with or as a participant in any transaction having such purposes or
effect.
<PAGE> 9
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
Dated: February 11, 1997
VANGUARD IV, L.P.
By: /s/ CURTIS K. MYERS
--------------------------------
Name: Curtis K. Myers
--------------------------------
Title: General Partner
--------------------------------
VANGUARD VENTURE PARTNERS
By: /s/ CURTIS K. MYERS
--------------------------------
Name: Curtis K. Myers
--------------------------------
Title: General Partner
--------------------------------
/s/ JACK M. GILL
-----------------------------------
JACK M. GILL
/s/ CURTIS K. MYERS
-----------------------------------
CURTIS K. MYERS
/s/ CLIFFORD H. HIGGERSON
-----------------------------------
CLIFFORD H. HIGGERSON
<PAGE> 10
EXHIBIT 1
AGREEMENT WITH RESPECT TO JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree that any statement of schedule 13G to be
filed with the Securities and Exchange Commission by any of the undersigned,
including any amendment thereto, with respect to the securities of CardioGenesis
Corporation may be filed by any of the undersigned as a joint filing on behalf
of all of the undersigned.
VANGUARD IV, L.P.
By: /s/ CURTIS K. MYERS
--------------------------------
Name: Curtis K. Myers
--------------------------------
Title: General Partner
--------------------------------
VANGUARD VENTURE PARTNERS
By: /s/ CURTIS K. MYERS
--------------------------------
Name: Curtis K. Myers
--------------------------------
Title: General Partner
--------------------------------
/s/ JACK M. GILL
-----------------------------------
JACK M. GILL
/s/ CURTIS K. MYERS
-----------------------------------
CURTIS K. MYERS
/s/ CLIFFORD H. HIGGERSON
-----------------------------------
CLIFFORD H. HIGGERSON
Dated: February 11, 1997
